Budesonide vs Drospirenone: side-by-side comparison
Budesonide (Inhaled corticosteroid) and Drospirenone (Progestogen with anti-mineralocorticoid and anti-androgen activity) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Budesonide | Drospirenone |
|---|---|---|
| Therapeutic class | Inhaled corticosteroid | Progestogen with anti-mineralocorticoid and anti-androgen activity |
| CAS | 51333-22-3 | 67392-87-4 |
| ATC | R03BA02 | G03AA12 |
| Molecular weight | 430.53 g/mol | 366.49 g/mol |
| Brands with this active ingredient | 1 | 2 |
What they share
Budesonide and Drospirenone share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Budesonide acts by a different mechanism than Drospirenone, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Budesonide: Budesonide binds intracellular glucocorticoid receptors and modulates gene transcription, decreasing the synthesis of proinflammatory cytokines, chemokines and adhesion molecules and reducing the recruitment of inflammat… Drospirenone: Drospirenone activates progesterone receptors to suppress ovulation and produce the contraceptive effect when combined with an estrogen.
Indications compared
Budesonide: Budesonide is approved as maintenance therapy in asthma and COPD as inhaled corticosteroid; as topical nasal therapy in allergic rhinitis and nasal polyps; and in extended-release oral formulations for the induction and… Drospirenone: Drospirenone in combination with ethinylestradiol is approved as combined oral contraception, treatment of moderate acne in women requesting contraception, and treatment of premenstrual dysphoric disorder.
Safety profile
Budesonide: Local adverse effects include oral candidiasis, dysphonia and pharyngeal irritation, mostly preventable by mouth rinsing after use. Drospirenone: Common adverse effects include menstrual irregularities, breast tenderness, headache, mood changes and nausea, mostly in the first 2–3 cycles.
Frequently asked questions
Is Budesonide better than Drospirenone? ▾
Budesonide and Drospirenone are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Budesonide and Drospirenone be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Budesonide
Products with Drospirenone
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.